Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on: December 30,2023

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on:December 30,2023

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024

Two drugs reverse a key pancreatic cancer step in the lab

byUniversity of FloridaReversal of ADM by TSA in primary human acinar cultures. Primary, human acini were cultured in Matrigel on glass chamber slides for 5 days. On day 5 of culture, 500 nM of

Updated on: December 28,2023

Two drugs reverse a key pancreatic cancer step in the lab

byUniversity of FloridaReversal of ADM by TSA in primary human acinar cultures. Primary, human acini were cultured in Matrigel on glass chamber slides for 5 days. On day 5 of culture, 500 nM of

Updated on:December 28,2023

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on: January 23,2024

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on:January 23,2024

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on: August 28,2024

Researchers devise novel solution to preventing relapse after CAR T-cell therapy

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainEven as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant

Updated on:August 28,2024

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr

Updated on: May 26,2024

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr

Updated on:May 26,2024

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin

Updated on: June 01,2024

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin

Updated on:June 01,2024

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on: March 14,2024

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on:March 14,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on: March 17,2025

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on:March 17,2025